The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 11, 2006, Pages 1135-1141

  McAvoy, Norma C ^a   Hayes, Peter C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Endoscopic band ligation; Salvage transjugular intrahepatic portosystemic stent shunt; Transjugular intrahepatic portosystemic stent shunt; Variceal haemorrhage

Indexed keywords

ANTIBIOTIC AGENT; CEFTIBUTEN; OCTREOTIDE; POLITEF; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ALGORITHM; BALLOON EMBOLIZATION; CLINICAL PROTOCOL; DRUG INDICATION; DRUG USE; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; OUTCOME ASSESSMENT; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SCLEROTHERAPY; STENT; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SALVAGE THERAPY; STENTS;

EID: 33749823421     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000236877.98472.58     Document Type: Review

References (48)

1. Jalan R, Hayes PC. UK Guidelines on the management of variceal haemorrhage in cirrhotic patients. Br Soc Gastroenterol Gut 2000; 46:III1-III15.
2. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319:983-989.
3. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta analytic review. Hepatology 1995; 22:332-354.
4. DeDombal FT, Clark JR, Clamp SE, Malizia G, Kofwal MR, Morgan AG. Prognostic factors in upper GI bleeding. Endoscopy 1986; 18 (Suppl 2):6-10.
5. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96:1552-1559.
6. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, Bosch J. Prognostic value of early measurement of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117:626-631.
7. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27:213-218.
8. Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodes J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence and extent of portalsystemic shunting. Hepatology 1989; 9:808-814.
9. Vlavianos P, Mac MP, Williams R, Westaby D. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Clin Sci (London) 1999; 96:475-481.
10. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108:1828-1834.
11. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27:1207-1212.
12. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta analysis. Hepatology 1999; 29:1655-1661.
13. Soares-Weiser K, Brezis M, Tur-kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002; 2:CD002907.
14. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal haemorrhage. Hepatology 1994; 20:34-38.
15. Selby WS, Norton ID, Pokorny CS, Bern RA. Bacteriaemia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomised control trial. Gastrointest Endosc 1994; 40:680-684.
16. Pauwels A, Mosteta-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal haemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802-806.
17. Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, Lee SD. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal haemorrhage. Am J Gastroenterol 1998; 93:962-966.
18. Williams R, Westaby D. Endoscopic sclerotherapy for oesophageal varices. Dig Dis Sci 1986; 31:108S-121S.
19. Van Stiegmann G, Cambre T, Sun JH. A new endoscopic elastic band ligating device. Gastrointest Endosc 1986; 32:230-233.
20. Young MF, Sanowski PA, Rasche R. Comparison and characterisation of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 1993; 39:119-122.
21. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346:865-868.
22. Argerinos A, Nevens S, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial. Lancet 1997; 350:1495-1499.
23. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Svostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French club for study portal hypertension. N Eng J Med 2001; 344:23-28.
24. Conn HO, Ramsby GR, Storer EH, Mutchnick MG, Joshi PH, Phillips MM, et al. Intra-arterial vasopressin in the treatment of upper gastrointestinal haemorrhage: a prospective controlled trial. Gastroenterology 1975; 68:211-221.
25. Sung JY, Chung SC, Yung MY, Lai CW, Lau JYW, Lee YT, et al. Prospective randomised study of the effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346:1666-1669.
26. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35:609-615.
27. Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33:454-459.
28. Richter GM, Noldge G, Palmaz JC, Rossle M, Slegerstetter V, Franke M, et al. Transjugular intrahepatic portocaval stent shunt. Preliminary clinical results. Radiology 1990; 174:1027-1030.
29. Rossle M, Richter GM, Noldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet 1989; ii:153.
30. Boyer TD. Transjugular intrahepatic portosystemic stent: current status. Gastroenterology 2003; 124:1700-1710.
31. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
32. Luketic VA, Sanyal AJ. Esophageal varices. II TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy. Gastroenterol Clin North Am 2000; 29:387-421.
33. Barton RE, Rosch J, Saxon RR, Lakin PC, Petersen BD, Keller FS, et al. TIPS: short and long term results: a survey of 1750 patients. Semin Intervent Radiol 1995; 12:364-367.
34. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal haemorrhage. Gastroenterology 1996; 110:832-839.
35. Haskal ZJ, Martin L, Cardella JF, Cole PE, Drooz A, Grassi CJ, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Intervent Radiol 2001; 12:131-136.
36. Haskal ZJ, Martin L, Cardella JF, Cole PE, Drooz A, Grassi CJ, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Intervent Radiol 2003; 14:S265-S270.
37. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic shunt for variceal haemorrhage. J Hepatol 1995; 23:123-128.
38. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunts: results of a prospective controlled study. Hepatology 1994; 20:46-55.
39. Somberg KA, Riegler JL, La Berge JM, Doherty-Simor MM, Bachetti P, Roberts JP, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995; 90:549-555.
40. McCormick PA, Dick R, Panagou EB, Chin JK, Greenslade L, McIntyre N, Burroughs AK. Emergency transjugular intrahepatic portosystemic stent shunt as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81:1324-1327.
41. Jalan R, John TG, Redhead DN, Garden OJ, Simpson KJ, Finlayson ND, Hayes PC. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90:1932-1937.
42. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffmann ML, Tisnado J, Cole PE. Transjugular intrahepatic portosystemic shunts for patients with active variceal haemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111:138-146.
43. Banares R, Casado M, Rodriguez-Laiz JM, Camunez F, Matilla A, Echenagusia A, et al. Urgent transjugular intrahepatic portosystemic stent shunt for correction of acute variceal bleeding. Am J Gastroenterol 1998; 93:75-79.
44. Azoulay D, Castaing D, Ichai P, Saliba F, Bismuth H. Intrahepatic portosystemic shunt as a salvage treatment of uncontrolled hemorrhage caused by rupture of esophageal varices in patients with liver cirrhosis. Press Med 1996; 25:842-846.
45. Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Smail A, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35:590-597.
46. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Marrero JM, Jimenza E, et al. Influence of portal hypertension and its early decompression TIPSS placement on the outcome of variceal bleeding. Hepatology 2004; 40:793-801.
47. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrarques G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomised study. Gastroenterology 2004; 126:469-475.
48. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of oesophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123:280-287.